View Clinical Trial (Medical Research Study)


A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES) - NCT00388206-60031(Clinical Trial 105028)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Gurnee
State:  
IL
Zip Code: 60031
Conditions: Colorectal Cancer - Non-Small Cell Lung Cancer
Purpose: This is an observational study designed to follow patients with metastatic or locally advanced and unresectable CRC, locally advanced or metastatic NSCLC (excluding predominant squamous histology) who are receiving Avastin in combination with first-line chemotherapy. Second-line metastatic CRC patients are also eligible. Patients who started their Avastin containing therapy <3 months prior to enrollment are eligible.
Study summary:
Criteria: Inclusion Criteria: - Signed Informed Consent Form - Metastatic or locally advanced and unresectable CRC or locally advanced or metastatic NSCLC (excluding predominant squamous histology) - Eligible for Avastin as a component of intended therapy - First-line chemotherapy (or second-line chemotherapy for CRC) plus Avastin initiated ≤ 3 months prior to study enrollment Exclusion Criteria: - Any medical condition, including mental illness or substance abuse, deemed by the investigator to be likely to interfere with a patient's ability to provide informed consent or comply with the treatment and follow-up, as specified by the investigator - Enrollment in a blinded, placebo-controlled bevacizumab trial
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 15, 2010
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.